These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6804681)

  • 21. Ventricular arrhythmias: current concepts.
    Nestico PF; Morganroth J
    Compr Ther; 1984 Sep; 10(9):32-6. PubMed ID: 6435947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine.
    Alpert JS; Haffajee CI; Young MD
    Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the drug treatment of ventricular arrhythmias.
    Nestico PF; Morganroth J
    Int J Dermatol; 1984 Oct; 23(8):558-64. PubMed ID: 6437997
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug therapy of cardiac arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Cardiol Clin; 1983 May; 1(2):305-22. PubMed ID: 6443562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical pharmacology of tocainide].
    Dorociak A; Rewerski W; Walczak F
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1440-4. PubMed ID: 3938534
    [No Abstract]   [Full Text] [Related]  

  • 26. Tocainide.
    Hanyok JJ
    Conn Med; 1985 Dec; 49(12):827-8. PubMed ID: 3936674
    [No Abstract]   [Full Text] [Related]  

  • 27. Tocainide: a new oral antiarrhythmic agent.
    Kutalek SP; Morganroth J; Horowitz LN
    Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
    Nademanee K; Singh BN
    JAMA; 1982 Jan; 247(2):217-22. PubMed ID: 6796709
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone].
    Kobayashi K; Itoh S; Fukuzaki H
    Nihon Rinsho; 1985 Nov; 43(11):2428-34. PubMed ID: 3936949
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 32. Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.
    Denaro CP; Benowitz NL
    Med Toxicol Adverse Drug Exp; 1989; 4(6):412-28. PubMed ID: 2513464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electrophysiologic and clinical study of tocainide, a new class IB drug].
    Vergara G; Disertori M; Bettini R; Stirpe E; Gramegna L; Furlanello F
    Minerva Cardioangiol; 1986 Nov; 34(11):711-9. PubMed ID: 3101001
    [No Abstract]   [Full Text] [Related]  

  • 34. Carbamate analogues of tocainide.
    Cernusková L; Benes L; Csöllei J; Tumová I; Svec P
    Pharmazie; 1994 Sep; 49(9):646-9. PubMed ID: 7526407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle.
    Toyama J; Kodama I; Kusunoki T; Ishihara T; Hattori Y; Yamada K
    Jpn Heart J; 1987 Mar; 28(2):273-85. PubMed ID: 3110457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer antiarrhythmic drugs.
    Coumel P; Krikler D; Rosen MR; Wellens HJ; Zipes DP
    Pacing Clin Electrophysiol; 1978 Oct; 1(4):521-8. PubMed ID: 95646
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration of the kinetics of tocainide in combined hepatic and renal insufficiency.
    Endell W; Oltmanns D; Pottage T
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):589-90. PubMed ID: 6420626
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analysis and toxicity of the anti-arrhythmia agent tocainide].
    Pfordt J
    Beitr Gerichtl Med; 1985; 43():161-7. PubMed ID: 3931622
    [No Abstract]   [Full Text] [Related]  

  • 40. Tocainide (Tonocard) for ventricular arrhythmias.
    Pepper GA
    Nurse Pract; 1985 Apr; 10(4):36, 38. PubMed ID: 3921883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.